Abel Hall LLC’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,249	Closed	-$9.89K	–	297
2025 Q1	$9.89K	Sell	12,249 -2,056	-14%	-$1.66K	0.01%	190
2024 Q4	$19.7K	Buy	+14,305	New	+$19.7K	0.01%	157